1. Lynch DA, Godwin JD, Safrin S, Starko KM, Hormel P, Brown KK, Raghu G,
King TE Jr, Bradford WZ, Schwartz DA, et al. High-resolution computed
tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J
Respir Crit Care Med. 2005;172(4):488–93.
2. Nishimura K, Kitaichi M, Izumi T, Nagai S, Kanaoka M, Itoh H. Usual interstitial
pneumonia: histologic correlation with high-resolution CT. Radiology. 1992;
182(2):337–42.
3. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and
treatment. International consensus statement. American Thoracic Society
(ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care
Med. 2000;161(2 Pt 1):646–64.
4. Collard HR, King TE Jr, Bartelson BB, Vourlekis JS, Schwarz MI, Brown KK.
Changes in clinical and physiologic variables predict survival in idiopathic
pulmonary fibrosis. Am J Respir Crit Care Med. 2003;168(5):538–42.
5. Jegal Y, Kim DS, Shim TS, Lim CM, Do Lee S, Koh Y, Kim WS, Kim WD, Lee
JS, Travis WD, et al. Physiology is a stronger predictor of survival than
pathology in fibrotic interstitial pneumonia. Am J Respir Crit Care Med.
2005;171(6):639–44.
6. King TE Jr, Safrin S, Starko KM, Brown KK, Noble PW, Raghu G, Schwartz DA.
Analyses of efficacy end points in a controlled trial of interferon-gamma1b
for idiopathic pulmonary fibrosis. Chest. 2005;127(1):171–7.
7. Latsi PI, du Bois RM, Nicholson AG, Colby TV, Bisirtzoglou D, Nikolakopoulou
A, Veeraraghavan S, Hansell DM, Wells AU. Fibrotic idiopathic interstitial
pneumonia: the prognostic value of longitudinal functional trends. Am J
Respir Crit Care Med. 2003;168(5):531–7.
8. Flaherty KR, Mumford JA, Murray S, Kazerooni EA, Gross BH, Colby TV, Travis
WD, Flint A, Toews GB, Lynch JP 3rd, et al. Prognostic implications of
physiologic and radiographic changes in idiopathic interstitial pneumonia.
Am J Respir Crit Care Med. 2003;168(5):543–8.
9. Cottin V, Hansell DM, Sverzellati N, Weycker D, Antoniou KM, Atwood M,
Oster G, Kirchgaessler KU, Collard HR, Wells AU. Effect of emphysema extent
on serial lung function in patients with idiopathic pulmonary fibrosis. Am J
Respir Crit Care Med. 2017;196(9):1162–71.
10. Sharafkhaneh A, Officer TM, Goodnight-White S, Rodarte JR, Boriek AM.
Novel method for measuring effects of gas compression on expiratory flow.
Am J Physiol Regul Integr Comp Physiol. 2004;287(2):R479–84.
11. Ingram RH Jr, Schilder DP. Effect of thoracic gas compression on the flowvolume curve of the forced vital capacity. Am Rev Respir Dis. 1966;94(1):56–63.
12. Piirila PL, Hodgson U, Wuorimaa T, Smith HJ, Sovijarvi AR. Thoracic gas
compression during forced expiration in patients with emphysema,
interstitial lung disease and obesity. BMC Pulmon Medi. 2014;14:34.
13. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV,
Cordier JF, Flaherty KR, Lasky JA, et al. An official ATS/ERS/JRS/ALAT
statement: idiopathic pulmonary fibrosis: evidence-based guidelines for
diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):
788–824.
Nakagawa et al. BMC Pulmonary Medicine
(2020) 20:214
14. Le Souef PN, Hughes DM, Landau LI. Shape of forced expiratory flowvolume curves in infants. Am Rev Respir Dis. 1988;138(3):590–7.
15. Shin HH, Sears MR, Hancox RJ. Prevalence and correlates of a 'knee' pattern
on the maximal expiratory flow-volume loop in young adults. Respirology.
2014;19(7):1052–8.
16. Ley B, Ryerson CJ, Vittinghoff E, Ryu JH, Tomassetti S, Lee JS, Poletti V,
Buccioli M, Elicker BM, Jones KD, et al. A multidimensional index and
staging system for idiopathic pulmonary fibrosis. Ann Intern Med. 2012;
156(10):684–91.
17. Wells AU, Desai SR, Rubens MB, Goh NS, Cramer D, Nicholson AG, Colby TV,
du Bois RM, Hansell DM. Idiopathic pulmonary fibrosis: a composite
physiologic index derived from disease extent observed by computed
tomography. Am J Respir Crit Care Med. 2003;167(7):962–9.
18. Nishimura M. Guideline of respiratory function tests--spirometry, flow-volume
curve, diffusion capacity of the lung. Nihon Kokyuki Gakkai Zasshi. 2004;Suppl:
1–56.
19. Nakagawa H, Nagatani Y, Takahashi M, Ogawa E, Tho NV, Ryujin Y, Nagao T,
Nakano Y. Quantitative CT analysis of honeycombing area in idiopathic
pulmonary fibrosis: correlations with pulmonary function tests. Eur J Radiol.
2016;85(1):125–30.
20. Sakai N, Mishima M, Nishimura K, Itoh H, Kuno K. An automated method to
assess the distribution of low attenuation areas on chest CT scans in
chronic pulmonary emphysema patients. Chest. 1994;106(5):1319–25.
21. Nakano Y, Muro S, Sakai H, Hirai T, Chin K, Tsukino M, Nishimura K, Itoh H,
Pare PD, Hogg JC, et al. Computed tomographic measurements of airway
dimensions and emphysema in smokers. Correlation with lung function. Am
J Respir Crit Care Med. 2000;162(3 Pt 1):1102–8.
22. Sun XW, Gu SY, Li QY, Ren L, Shen JM, Wan HY, Huang SG, Deng WW.
Pulmonary function parameters in high-resolution computed tomography
phenotypes of chronic obstructive pulmonary disease. Am J Med Sci. 2015;
349(3):228–33.
23. Nemoto T, Shibata Y, Osaka D, Abe S, Inoue S, Tokairin Y, Igarashi A,
Yamauchi K, Kimura T, Kishi H, et al. Impact of cigarette smoking on
maximal expiratory flows in a general population: the Takahata study. Intern
Med. 2011;50(21):2547–55.
24. Mead J, Turner JM, Macklem PT, Little JB. Significance of the relationship
between lung recoil and maximum expiratory flow. J Appl Physiol. 1967;
22(1):95–108.
25. Yamashiro T, Moriya H, Matsuoka S, Nagatani Y, Tsubakimoto M, Tsuchiya N,
Murayama S. Asynchrony in respiratory movements between the
pulmonary lobes in patients with COPD: continuous measurement of lung
density by 4-dimensional dynamic-ventilation CT. Int J Chronic Obstruct
Pulmon Dis. 2017;12:2101–9.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Page 10 of 10
...
論文の公開元へ
